| 1 | 1 | | 88R4755 CJD-D |
|---|
| 2 | 2 | | By: Perry S.B. No. 1747 |
|---|
| 3 | 3 | | |
|---|
| 4 | 4 | | |
|---|
| 5 | 5 | | A BILL TO BE ENTITLED |
|---|
| 6 | 6 | | AN ACT |
|---|
| 7 | 7 | | relating to the medical use of low-THC cannabis by patients with |
|---|
| 8 | 8 | | certain medical conditions. |
|---|
| 9 | 9 | | BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: |
|---|
| 10 | 10 | | SECTION 1. Section 169.001(3), Occupations Code, is amended |
|---|
| 11 | 11 | | to read as follows: |
|---|
| 12 | 12 | | (3) "Low-THC cannabis" means the plant Cannabis sativa |
|---|
| 13 | 13 | | L., and any part of that plant or any compound, manufacture, salt, |
|---|
| 14 | 14 | | derivative, mixture, preparation, resin, or oil of that plant that |
|---|
| 15 | 15 | | contains not more than five [one] percent by weight of |
|---|
| 16 | 16 | | tetrahydrocannabinols. |
|---|
| 17 | 17 | | SECTION 2. Section 169.003, Occupations Code, is amended to |
|---|
| 18 | 18 | | read as follows: |
|---|
| 19 | 19 | | Sec. 169.003. PRESCRIPTION OF LOW-THC CANNABIS. (a) A |
|---|
| 20 | 20 | | physician described by Section 169.002 may prescribe low-THC |
|---|
| 21 | 21 | | cannabis to a patient if: |
|---|
| 22 | 22 | | (1) the patient is a permanent resident of the state; |
|---|
| 23 | 23 | | (2) the physician complies with the registration |
|---|
| 24 | 24 | | requirements of Section 169.004; and |
|---|
| 25 | 25 | | (3) the physician certifies to the department that: |
|---|
| 26 | 26 | | (A) the patient is diagnosed with: |
|---|
| 27 | 27 | | (i) epilepsy; |
|---|
| 28 | 28 | | (ii) a seizure disorder; |
|---|
| 29 | 29 | | (iii) multiple sclerosis; |
|---|
| 30 | 30 | | (iv) spasticity; |
|---|
| 31 | 31 | | (v) amyotrophic lateral sclerosis; |
|---|
| 32 | 32 | | (vi) autism; |
|---|
| 33 | 33 | | (vii) cancer; |
|---|
| 34 | 34 | | (viii) an incurable neurodegenerative |
|---|
| 35 | 35 | | disease; |
|---|
| 36 | 36 | | (ix) post-traumatic stress disorder; [or] |
|---|
| 37 | 37 | | (x) a condition that causes chronic pain, |
|---|
| 38 | 38 | | for which a physician would otherwise prescribe an opioid; |
|---|
| 39 | 39 | | (xi) a medical condition that is approved |
|---|
| 40 | 40 | | for a research program under Subchapter F, Chapter 487, Health and |
|---|
| 41 | 41 | | Safety Code, and for which the patient is receiving treatment under |
|---|
| 42 | 42 | | that program; or |
|---|
| 43 | 43 | | (xii) a debilitating medical condition |
|---|
| 44 | 44 | | designated by the Department of State Health Services under |
|---|
| 45 | 45 | | Subsection (b); and |
|---|
| 46 | 46 | | (B) the physician determines the risk of the |
|---|
| 47 | 47 | | medical use of low-THC cannabis by the patient is reasonable in |
|---|
| 48 | 48 | | light of the potential benefit for the patient. |
|---|
| 49 | 49 | | (b) The Department of State Health Services by rule may |
|---|
| 50 | 50 | | designate debilitating medical conditions for which a physician may |
|---|
| 51 | 51 | | prescribe low-THC cannabis under this section. |
|---|
| 52 | 52 | | SECTION 3. This Act takes effect September 1, 2023. |
|---|